NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Alibaba
BABA
US Stock MarketDetailed Quotes
DNA Ginkgo Bioworks
- 9.477
- -0.813-7.90%
Trading Feb 26 10:01 ET
549.96MMarket Cap-0.90P/E (TTM)
9.670High8.500Low1.32MVolume8.900Open10.290Pre Close12.07MTurnover3.31%Turnover RatioLossP/E (Static)58.03MShares52.80052wk High0.77P/B376.98MFloat Cap5.26052wk Low--Dividend TTM39.78MShs Float634.560Historical High--Div YieldTTM11.37%Amplitude5.260Historical Low9.172Avg Price1Lot Size
Ginkgo Bioworks Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.71%227.04M | 26.16%43.85M | 60.65%89.05M | -30.24%56.21M | -52.98%37.94M | -47.36%251.46M | -64.64%34.76M | -16.52%55.43M | -44.29%80.57M | -52.08%80.7M |
| Operating revenue | -9.71%227.04M | 26.16%43.85M | 60.65%89.05M | -30.24%56.21M | -52.98%37.94M | -47.36%251.46M | -64.64%34.76M | -16.52%55.43M | -44.29%80.57M | -52.08%80.7M |
| Cost of revenue | -17.51%44.55M | 45.55%9.62M | 73.38%12M | -24.18%13.72M | -58.87%9.2M | -73.55%54.01M | -78.12%6.61M | -71.92%6.92M | -71.69%18.1M | -73.81%22.38M |
| Gross profit | -7.57%182.5M | 21.61%34.23M | 58.83%77.04M | -31.99%42.49M | -50.72%28.74M | -27.80%197.45M | -58.65%28.14M | 16.20%48.51M | -22.59%62.47M | -29.70%58.33M |
| Operating expense | -30.59%670.22M | -35.19%133.67M | -45.83%129.3M | -18.70%200.51M | -24.57%206.74M | -61.10%965.65M | -31.00%206.26M | -65.74%238.69M | -66.15%246.62M | -63.86%274.07M |
| Selling and administrative expenses | -36.07%246.16M | -35.78%57.3M | -36.25%52.29M | -35.23%66.29M | -36.92%70.29M | -73.07%385.03M | -26.49%89.22M | -81.15%82.03M | -76.66%102.34M | -74.37%111.43M |
| -General and administrative expense | -36.07%246.16M | -35.78%57.3M | -36.25%52.29M | -35.23%66.29M | -36.92%70.29M | -73.07%385.03M | -26.49%89.22M | -81.15%82.03M | -76.66%102.34M | -74.37%111.43M |
| Research and development costs | -26.96%424.06M | -34.74%76.38M | -50.85%77.01M | -6.97%134.22M | -16.10%136.46M | -44.84%580.62M | -34.08%117.04M | -40.08%156.66M | -50.26%144.28M | -49.74%162.64M |
| Operating profit | 36.51%-487.73M | 44.17%-99.45M | 72.52%-52.26M | 14.19%-158.02M | 17.49%-178M | 65.22%-768.2M | 22.85%-178.12M | 70.96%-190.18M | 71.57%-184.15M | 68.06%-215.75M |
| Net non-operating interest income expense | -32.57%38.52M | -45.17%7.24M | -38.41%9.25M | -28.13%10.31M | -19.48%11.71M | 183.41%57.12M | 16.54%13.21M | 135.42%15.02M | 533.79%14.35M | 8,117.51%14.55M |
| Non-operating interest income | -32.52%38.61M | -45.52%7.25M | -38.41%9.25M | -28.13%10.31M | -19.48%11.71M | 182.39%57.22M | --13.3M | --15.02M | 533.79%14.35M | 8,117.51%14.55M |
| Non-operating interest expense | 1.08%94K | --4K | ---- | ---- | ---- | -12.26%93K | ---- | ---- | ---- | ---- |
| Other net income (expense) | 45.95%-98.3M | 66.69%-15.65M | 89.22%-13.77M | -1,910.53%-69.28M | 111.15%411K | -369.85%-181.87M | -248.31%-46.99M | -491.41%-127.75M | 86.27%-3.45M | -104.47%-3.69M |
| Gain on sale of security | 53.43%-23.13M | -262.89%-12.55M | 84.36%-5.38M | 45.59%-3.59M | 68.95%-1.6M | -169.32%-49.66M | -122.28%-3.46M | -142.43%-34.43M | 56.46%-6.6M | -106.04%-5.17M |
| Earnings from equity interest | --0 | --0 | --0 | --0 | --0 | 93.98%-2.64M | -111.19%-1.12M | --0 | 99.34%-67K | 93.06%-1.45M |
| Special income (charges) | 43.02%-79.04M | 90.22%-4.16M | 89.65%-9.96M | ---64.92M | ---- | -534.98%-138.71M | ---42.5M | -701.73%-96.21M | --0 | ---- |
| -Less：Restructuring and merger&acquisition | --24.17M | --4.16M | --2.95M | --17.07M | ---- | ---- | ---- | --0 | --0 | ---- |
| -Less:Impairment of capital assets | -50.26%47.86M | --0 | --0 | --47.86M | ---- | --96.21M | --0 | --96.21M | --0 | ---- |
| -Gain on sale of business | 83.50%-7.01M | --0 | ---7.01M | ---- | ---- | -233.28%-42.5M | ---42.5M | --0 | ---- | ---- |
| Other non- operating income (expenses) | -57.65%3.87M | 1,027.96%1.05M | -45.66%1.57M | -123.76%-766K | -31.18%2.02M | 19.70%9.14M | -98.49%93K | 527.96%2.89M | 1,301.74%3.22M | 52.58%2.93M |
| Income before tax | 38.68%-547.51M | 49.10%-107.86M | 81.26%-56.78M | -25.25%-216.99M | 19.04%-165.88M | 57.91%-892.94M | -12.80%-211.89M | 54.80%-302.91M | 74.17%-173.25M | 65.44%-204.89M |
| Income tax | -574.65%-479K | -64.14%-325K | -1,604.55%-375K | 183.58%190K | -62.20%31K | 99.53%-71K | 98.66%-198K | 21.43%-22K | 248.89%67K | 144.57%82K |
| Net income | 38.73%-547.03M | 49.20%-107.53M | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.61%-892.87M | -22.31%-211.69M | 54.80%-302.89M | 74.15%-173.32M | 65.41%-204.97M |
| Net income continuous Operations | 38.73%-547.03M | 49.20%-107.53M | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.61%-892.87M | -22.31%-211.69M | 54.80%-302.89M | 74.15%-173.32M | 65.41%-204.97M |
| Minority interest income | 0 | |||||||||
| Net income attributable to the parent company | 38.73%-547.03M | 49.20%-107.53M | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.58%-892.87M | -20.65%-211.69M | 54.80%-302.89M | 74.09%-173.32M | 65.29%-204.97M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 29K | 184K | -24.06%464K | 0 | 0 | 0 | 0 | 611K | ||
| Net income attributable to common stockholders | 38.73%-547.03M | 49.20%-107.53M | 81.37%-56.43M | -25.42%-217.37M | 19.07%-166.38M | 57.65%-892.87M | -18.52%-211.69M | 54.80%-302.89M | 74.09%-173.32M | 65.19%-205.58M |
| Basic earnings per share | 42.72%-10.54 | 53.60%-2 | 82.61%-1.08 | -22.22%-4.4 | 27.27%-3.2 | 63.20%-18.4 | -19.72%-4.31 | 62.13%-6.21 | 78.05%-3.6 | 70.27%-4.4 |
| Diluted earnings per share | 42.72%-10.54 | 53.60%-2 | 82.61%-1.08 | -22.22%-4.4 | 27.27%-3.2 | 63.20%-18.4 | -7.75%-4.31 | 62.13%-6.21 | 78.05%-3.6 | 70.27%-4.4 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |